COVID‑19 (SARS‑CoV‑2)* rapid antigen testing
BD Veritor™ Plus System
Used as part of a comprehensive coronavirus mitigation program, fast, easy-to-use testing for SARS-CoV-2 (the novel or new coronavirus that causes COVID-19) provides health care workers information they can use to actively detect the virus and decrease the likelihood of spread.
What is COVID‑19?
There are seven known human coronaviruses¹. SARS-CoV-2, more commonly referred to as COVID-19, is a novel or new virus which means a person's immune system has not been exposed to it yet. SARS-CoV-2 is the coronavirus that caused the COVID-19 pandemic².
In COVID-19, the name reflects the following:²
To learn more about how to slow the spread of COVID-19, visit the CDC website for more information.
Why rapid point-of-care testing matters
As the global healthcare community searches for effective methods for addressing COVID-19, the important role of testing is becoming more apparent. There are currently two kinds of testing available for SARS-CoV-2: diagnostic testing that detects either genetic material (RNA) or proteins (antigens) from the infecting virus, and antibody testing that detects the body’s immune response to infection (antibodies).
The BD Veritor™ Plus System provides simple and reliable rapid antigen testing at the point-of-care.
Types of respiratory diagnostic testing
Rapid antigen test Detects proteins (antigens) from the infecting virus
Molecular diagnostic (PCR) test Detects genetic material (RNA) from the infecting virus
Serology test Detects the body’s immune response to infection (antibodies)
BD Veritor™ System for Rapid Detection of SARS‑CoV‑2*
The BD Veritor™ System for Rapid Detection of SARS‑CoV‑2* antigen test detects nucleoproteins from the SARS‑CoV‑2 virus in as little as 15 minutes⁴, and can be conducted
at the point-of-care.
The BD Veritor™ Plus System provides rapid, reliable results, and offers one-button functionality for workflow flexibility, allowing health care professionals to confidently use the Analyzer.
Simple sample collection
Rapid, reliable results
Convenient portability
Reporting options available
How to perform COVID‑19 testing with the BD Veritor™ Plus System*
The BD Veritor™ System for Rapid Detection of SARS‑CoV‑2* antigen test detects proteins from the SARS‑CoV‑2 virus. A nasal swab is used to collect the specimen from a patient suspected of having COVID‑19. The sample is prepared, added to the assay cartridge, incubated and then interpreted by the Analyzer.
For complete instructions for use, refer to our user documentation.
Remove cap and insert swab into tube
Mix sample with reagent, then remove swab
Take care not to splash contents out of the tube
Close dispensing cap, then dispense sample into test device
The
Analyzer interprets the results
For Walk Away mode, insert test device immediately
For Analyze Now mode, insert test device after 15-minute test incubation period
To learn more about how to administer rapid antigen testing with the BD Veritor™ Plus System, see our simple user guides in the resource library.
BD Veritor™ Plus System ordering and reimbursement
As your facility continues to provide valuable rapid diagnostic testing, you may need to reorder. Please click here for more information.
Resources